By integrating actionable environmental insights into their health app, the global allergy specialists ALK make a positive difference in the lives of sensitive seasonal allergy sufferers – reducing app removals by 50%!
Download the ALK Allergy App Case Study to Learn:
- How ALK stays educational and relevant by providing personalized environmental information, without scaring their patients.
- How ALK makes better connections with patients through digital engagement.
- Identify additional opportunities available in the medical industry for improving patient allergy condition management for allergies, asthma, COPD and other respiratory sensitivities.
Who is ALK ?
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. The company provides allergy immunotherapy treatments and other products and services for people with allergies, as well as for allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,300 people worldwide and is listed on NASDAQ.
A young company with an old soul, klarify.me started as a consumer-focused start-up under the umbrella of parent company ALK. Their mission is to make life with allergies as simple and as limitless as possible.
Klarify.me has always understood the importance of communicating not just pollen information to their pollen-sensitive (allergic) users, but also for understanding the impact of air pollution on the health of seasonal allergy sufferers. With their Klara mobile app, ALK aims to empower people to better manage their allergies and health.
ALK Teams Up with BreezoMeter
In looking for ways to improve the Klara allergy app, the ALK team knew they could benefit from increased user engagement by integrating BreezoMeter’s environmental information into their health app experience:
In order to provide the best data available, ALK partnered up with BreezoMeter. It can be a jungle to find valid and easy-to-understand pollen and air quality data as a user.” – Louise Kristine Hjernø, Global Head of Digital Projects, Consumer Division, ALK.